Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver

Gu Can-li; Zhang Yun-ke; Fu Yue-xiao; Yang Shao-feng; Li Xin-qiang

doi:10.1007/s11655-007-0275-6

Your Location：

Home >

Browse articles >

Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver

OriginalPaper | Updated：2021-08-27

- Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver
- Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver
- 中国结合医学杂志（英文版） 2007年13卷第4期页码：275-279
- Affiliations：
  
  1. People’s Hospital of Ruyang County,China
  2. The First Affiliated Hospital of Henan College of Traditional Chinese Medicine,China
  3. Traditional Chinese Medicine Hospital of Ruyang County,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-007-0275-6
  中图分类号：
- 纸质出版日期：2007，
Scan for full text
Gu, Cl., Zhang, Yk., Fu, Yx. et al. Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver., Chin. J. Integr. Med. 13, 275–279 (2007). https://doi.org/10.1007/s11655-007-0275-6

Gu Can-li, Zhang Yun-ke, Fu Yue-xiao, et al. Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver[J]. Chinese Journal of Integrative Medicine, 2007,13(4):275-279.
Gu, Cl., Zhang, Yk., Fu, Yx. et al. Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver., Chin. J. Integr. Med. 13, 275–279 (2007). https://doi.org/10.1007/s11655-007-0275-6 DOI：

Gu Can-li, Zhang Yun-ke, Fu Yue-xiao, et al. Effect of Tiaozhi Yanggan Decoction (调脂养肝汤) in treating patients with non-alcoholic fatty liver[J]. Chinese Journal of Integrative Medicine, 2007,13(4):275-279. DOI： 10.1007/s11655-007-0275-6.

摘要

To observe the clinical efficacy and safety of Tiaozhi Yanggan Decoction (调脂养肝汤

TZYGD) in treating non-alcoholic fatty liver. One hundred and thirty-eight patients were enrolled and randomized into two groups according to the random number table in a ratio of 3:1

with 8 cases eventually dropping out. The symptoms

signs

liver function markers

blood lipids

iconographic indices and clinical comprehensive efficacy after a 12-week treatment course were assessed in 101 patients treated with TZYGD in the treated group and 29 patients treated with Thiola in the control group. The total effective rate in the treated group and the control group was 81.19% and 68.97%

respectively

showing a significant difference between the two groups with the former being significantly higher than the latter (P<0.05). Moreover

the improvements in the symptoms

signs

liver function

blood lipids and iconographic indices in the treated group were favorable with no serious adverse reactions. TZYGD is effective and highly safe in treating non-alcoholic fatty liver.

Abstract

To observe the clinical efficacy and safety of Tiaozhi Yanggan Decoction (调脂养肝汤

TZYGD) in treating non-alcoholic fatty liver. One hundred and thirty-eight patients were enrolled and randomized into two groups according to the random number table in a ratio of 3:1

with 8 cases eventually dropping out. The symptoms

signs

liver function markers

blood lipids

respectively

showing a significant difference between the two groups with the former being significantly higher than the latter (P<0.05). Moreover

the improvements in the symptoms

signs

liver function

blood lipids and iconographic indices in the treated group were favorable with no serious adverse reactions. TZYGD is effective and highly safe in treating non-alcoholic fatty liver.

关键词

non-alcoholic fatty liverTiaozhi Yanggan decoctionTraditional Chinese Medicine Therapyefficacy assessment

Keywords

non-alcoholic fatty liverTiaozhi Yanggan decoctionTraditional Chinese Medicine Therapyefficacy assessment

references

Fan JG. Steatohepatitis studies in China. World Chin J Digestol (Chin) 2001;9(1):6–10.

Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. Guidelines for diagnosis and treatment of alcoholic liver diseases. Chin J Hepatol (Chin) 2006;14(3):161–163.

Ji G, Fan JG, Chen JJ, et al. Clinical study on treatment of non-alcoholic fatty liver of damp-heat syndrome type by Danning tablet. Chin J Integr Tradit West Med (Chin) 2005;25(6):485–488.

Hu YY. To strengthen further study on treatment of lipoidal liver diseases by traditional Chinese medicine. Chin J Integr Tradit West Med (Chin) 2004;24(1):12.

He XY. Rhizoma Alismatis and hyperlipemia, atherosclerosis, and fatty liver. Chin J Integr Tradit West Med (Chin) 1981;1(2):114–116.

Mo JR, Xu G. Sixty patients of fatty liver treated by Shugan Huazhi diet. J Sichuan Tradit Chin Medn (Chin) 2001;19(8):45.

FULL TEXT LINK

More>

浏览量

346

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

A clinical study on global TCM therapy in treating senile advanced non-small cell lung cancer

A survey on treatment of dry eye by traditional chinese medicine and integrative Chinese and Western medicine

A clinical study of Suogudan Granule in the treatment of rheumatoid arthritis

Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs

Clinical study on the effect of Shengxueling on idiopathic thrombocytopenic purpura